Author:
Piccart M.J.,de Valeriola D.,Dal Lago L.,de Azambuja E.,Demonty G.,Lebrun F.,Bernard-Marty Ch.,Colozza M.,Cufer T.
Reference31 articles.
1. Primary Therapy of Early Breast Cancer. Abstracts of the eighth international conference, St. Gallen, Switzerland, March 12–15, 2003. Breast 2003;12(Suppl 1):S1–52.
2. Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer;Henderson;J Clin Oncol,2003
3. Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28;Mamounas;J Clin Oncol,2005
4. Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: Cancer and Leukemia Group B 9344;Sartor;J Clin Oncol,2005
5. Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献